Posts tagged “GSK”
The National Institutes of Health announced Thursday that it is launching the safety trial on a vaccine developed by the agency's National Institute of Allergy and Infectious Diseases and GlaxoSmithKline. Beginning Tuesday, it will test 20 healthy adult volunteers to see if the virus is safe and triggers an adequate response in their immune systems.
A possible vaccine to treat the spreading Ebola outbreak in Africa could be coming from GSK. Plus, a lab in Greenville could be a site where a treatment is produced.
As more companies step up efforts to develop vaccines targeting ebola and the disease outbreak spreads in Africa, a doctor at Duke University warns that using untested drugs "could prove disastrous."
Another day, another headache in the global press for GlaxoSmithKline and its CEO Andrew Witty. This time it's an in-depth report in The Wall Street Journal in which some investors question Witty's performance as the drug giant fights lagging sales and scandal.
A World Health Organization official says the first ebola vaccine could be available in 2015. It's being developed by GlaxoSmithKline. However, the drug giant says "it's too early" to speculate on timing.
"The root of the problem really from where I'm sitting is the way GSK behaved in this matter," the son of convicted investigator tells London-based broadcaster Sky News. GSK has said it hired the couple to investigate a security breach but not bribery allegations.
Peter Humphrey and Yingzeng Yu worked under contract for British pharmaceutical giant GlaxoSmithKline, which is accused in a separate case of bribing Chinese doctors and hospitals to use its products. Authorities have not indicated whether these two cases are linked as the fraud trial continues in China.
In the latest Bulldog roundup of life science and technology news: GSK gets a lift as Express Scripts reinstates lung drug Advair; Comcast initiates amnesty, free service for the poor; FCC's Friends and Family Plan; and Wikipedia link to be hidden in Google under 'right to be forgotten' law.
In the latest Bulldog roundup of life science and technology news: The real difference between Microsoft and Apple; Novo Nordisk leapfrogs Glaxo as U.K. drug giant declines; U.S. Map shows more community-owned broadband networks than expected; Google email scan leads to sex offender arrest; and Metrics Contract Services adopt new name and logo.
The experimental shot is the most advanced candidate vaccine for malaria but results from previous trials have been disappointing. Research published in 2012 showed the shot only reduced malaria cases by about 30 percent in babies aged six to 12 weeks, the target age for immunization.
Drug giant GlaxoSmithKline, hurt in part by a 20 percent decline in sales in China where the company is under criminal investigation, reports revenues and earnings that missed analysts' expectations on Wednesday. GSK also reduced its growth forecast for 2014 from as much as 8 percent to "basically similar" to 2013 and says it can't estimate what the financial impact could be from the China case.
Even with sales and profits declining sharply from a year ago, a cut in a growth forecast for this year and continuing legal issues resulting from a criminal investigation in China, GSK's chief executive officer Andrew Witty puts a positive spin on the state of the company in a video interview.
GlaxoSmithKline, which operates a huge drug manufacturing facility in Zebulon, is investing as much as $25 million to license a technology platform from a California firm as part of efforts to develop new drugs. But GSK isn't bringing the platform to N.C., at least initially.
Chinese authorities have indicted British and American investigators hired by GlaxoSmithKline on charges of illegally obtaining and selling private information, state media reported Monday, as the Briton blamed the pharmaceutical company for misleading and using him.
U.S. diplomats will be barred from the trial in China of an American investigator for GlaxoSmithKline and her British husband who are charged with improperly selling personal information, according to a spokesman for the U.S. Embassy in Beijing.
"Revealed: Sex tape blew open Glaxo's China bribery scandal," reads the big headline in the prestigious The Sunday Times says. A "clandestinely" filmed video of GSK's top China executive that was sent to GSK's CEO set off a company investigation that in turn ignited China's bribery probe against the drug giant, the paper says. In a statement to Reuters, GSK confirms the tape's existence.
Drug giant GlaxoSmithKline will pay 44 states, including North Carolina, some $105 million to settle a case over improper drug marketing. North Carolina will receive $2.5 million. It's the third time since 2011 that GSK is paying N.C. as part of settlements for investigations.
The former Midwestern pharmaceutical sales rep "carried the bag" all the way to the office of CEO and chairman of GlaxoWellcome, and co-led its integration into today's GSK tells entrepreneurs they are the future as he reflects on a remarkable career.